Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-055400
Filing Date
2021-09-09
Accepted
2021-09-09 21:30:59
Documents
2
Period of Report
2021-09-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2173
2 POA DOCUMENT poa.txt EX-24.3_1007765 4059
  Complete submission text file 0001209191-21-055400.txt   7565
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Issuer) CIK: 0000921299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FIBROGEN, INC. 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address
Graham Juan (Reporting) CIK: 0001879223 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36740 | Film No.: 211245693